is byetta a glp-1 Key clinical trials with the mimetic exenatide (Byetta) in type 2 GLP-1 mimetics like exenatide for

Peptides that degrade too quickly in saliva Saliva contains peptidases and other enzymes that, while less aggressive than gastric enzymes, still degrade susceptible peptides

Is the hair loss or hair shedding permanent

However, nasal spray's rapid onset may benefit acute injuries, while oral administration might better support chronic gastrointestinal issues through direct tissue contact

Some prefer the once-weekly simplicity

The transition from an IV infusion or SC vial to an SC injection device requires several chemistry, manufacturing and controls (CMC) development activities, as well as clinical and non-clinical, depending on the timing and scope of the change: Formulation development Primary packaging selection and integration with formulation Device selection and device development Drug-device integration Drug product manufacturing process development Bridging studies Comparative stability studies, including real-time and accelerated stress stability and characterisation Non-clinical studies Clinical studies